Nostrum Pharmaceuticals is engaged in the formulation and commercialization of specialty pharmaceutical products and controlled-release, orally-administered, branded and generic drugs. With controlled-release drug delivery technologies incresaingly used to improve therapy, these technologies allow for the development of patient-friendly dosage forms, reducing the frequency of drug administration and often improving patient compliance. Controlled-release pharmaceuticals can be especially beneficial for certain patient populations, such as the elderly, who often require several medications with differing dosing regimens. Nostrum Pharmaceuticals has a rich portfolio of approved and filed Intellectual Property supported by research and development in India through its Enem Nostrum facility as well as technology transfer and production at its Nostrum Laboratories, Inc facility in Kansas City, MO.
